Carillon Tower Advisers’s Patterson-UTI PTEN Stock Holding History

Carillon Tower Advisers’s Portfolio PTEN Stock Details PTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,302,490	Closed	-$13.7M	–	475
2019 Q4	$13.7M	Sell	1,302,490 -773,925	-37%	-$7M	0.09%	302
2019 Q3	$17.8M	Buy	2,076,415 +887,790	+75%	+$8.71M	0.12%	263
2019 Q2	$13.7M	Sell	1,188,625 -229,125	-16%	-$2.95M	0.09%	294
2019 Q1	$19.9M	Buy	1,417,750 +810,625	+134%	+$10.6M	0.14%	242
2018 Q4	$6.28M	Buy	+607,125	New	+$8.95M	0.05%	344
2018 Q3	–	Sell	-289,850	Closed	-$5.22M	–	464
2018 Q2	$5.22M	Sell	289,850 -98,875	-25%	-$1.98M	0.04%	379
2018 Q1	$6.81M	Buy	+388,725	New	+$8.12M	0.05%	345

Other funds holding PTEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Carillon Tower Advisers's PTEN Position: Q1 2020 in Review

Carillon Tower Advisers sold out of Patterson-UTI (PTEN) in Q1 2020, closing a stake of 1,302,490 shares — an estimated $13.7M sold.

Carillon Tower Advisers first reported a position in PTEN in Q1 2018 and held it in 7 quarters. The position peaked at $19.9M in Q1 2019. 257 funds tracked by Wall St. Rank hold PTEN as of Q1 2020.

Carillon Tower Advisers reported no remaining Patterson-UTI position as of Q1 2020 after selling out during the quarter.
Carillon Tower Advisers sold 1,302,490 Patterson-UTI shares in Q1 2020, an estimated $13.7M.
Carillon Tower Advisers first reported a position in Patterson-UTI in Q1 2018 and held it in 7 quarters.
Carillon Tower Advisers's Patterson-UTI position peaked at $19.9M in Q1 2019.
257 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2020.

Based on Carillon Tower Advisers's 13F filing for Q1 2020, filed 11 May 2020.